| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | SLC6A4 CACNA1C CACNA1D ABCG4 CACNA1F ABCG1 SLC38A10 SLC18A1 SLC22A14 SLC22A5 SCN4A SCN5A SLC49A4 PKD2 SCN10A ATP11C SLC45A2 SLC35B2 SLC43A3 TMC5 SLC15A3 TMCO1 SLC38A6 SLC39A8 RYR2 SLC5A4 | 1.67e-12 | 1289 | 79 | 26 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC6A4 CACNA1C CACNA1D ABCG4 CACNA1F ABCG1 SLC38A10 SLC18A1 SLC22A14 SLC22A5 SCN4A SCN5A SLC49A4 PKD2 SCN10A SLC45A2 SLC35B2 SLC43A3 TMC5 SLC15A3 TMCO1 SLC38A6 SLC39A8 RYR2 SLC5A4 | 1.74e-12 | 1180 | 79 | 25 | GO:0022857 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC6A4 CACNA1C CACNA1D CACNA1F SLC18A1 SCN4A SCN5A PKD2 SCN10A SLC45A2 SLC15A3 TMCO1 SLC39A8 RYR2 SLC5A4 | 2.02e-08 | 627 | 79 | 15 | GO:0022890 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC6A4 CACNA1C CACNA1D CACNA1F SLC18A1 SCN4A SCN5A PKD2 SCN10A TMCO1 SLC39A8 RYR2 SLC5A4 | 3.27e-08 | 465 | 79 | 13 | GO:0046873 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC6A4 CACNA1C CACNA1D CACNA1F SLC18A1 SCN4A SCN5A PKD2 SCN10A SLC45A2 SLC15A3 TMCO1 SLC39A8 RYR2 SLC5A4 | 4.30e-08 | 664 | 79 | 15 | GO:0008324 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC6A4 CACNA1C CACNA1D CACNA1F SLC18A1 SCN4A SCN5A PKD2 SCN10A SLC45A2 TMC5 SLC15A3 TMCO1 SLC39A8 RYR2 SLC5A4 | 6.83e-08 | 793 | 79 | 16 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC6A4 CACNA1C CACNA1D CACNA1F SLC18A1 SCN4A SCN5A PKD2 SCN10A SLC45A2 SLC15A3 TMCO1 SLC39A8 RYR2 SLC5A4 | 2.39e-07 | 758 | 79 | 15 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | SLC6A4 CACNA1C CACNA1D CACNA1F SCN4A SCN5A PKD2 SCN10A TMCO1 RYR2 | 9.89e-07 | 343 | 79 | 10 | GO:0005261 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | SLC6A4 CACNA1C CACNA1D CACNA1F SCN4A SCN5A PKD2 SCN10A TMC5 TMCO1 RYR2 | 1.86e-06 | 459 | 79 | 11 | GO:0005216 |
| GeneOntologyMolecularFunction | symporter activity | 2.16e-06 | 150 | 79 | 7 | GO:0015293 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 3.17e-06 | 26 | 79 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 5.16e-06 | 171 | 79 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | S-acyltransferase activity | 5.75e-06 | 30 | 79 | 4 | GO:0016417 | |
| GeneOntologyMolecularFunction | channel activity | SLC6A4 CACNA1C CACNA1D CACNA1F SCN4A SCN5A PKD2 SCN10A TMC5 TMCO1 RYR2 | 6.72e-06 | 525 | 79 | 11 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | SLC6A4 CACNA1C CACNA1D CACNA1F SCN4A SCN5A PKD2 SCN10A TMC5 TMCO1 RYR2 | 6.84e-06 | 526 | 79 | 11 | GO:0022803 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 7.69e-06 | 119 | 79 | 6 | GO:0015294 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.22e-05 | 129 | 79 | 6 | GO:0005262 | |
| GeneOntologyMolecularFunction | ABC-type sterol transporter activity | 1.55e-05 | 2 | 79 | 2 | GO:0034041 | |
| GeneOntologyMolecularFunction | nicotinic acid receptor activity | 1.55e-05 | 2 | 79 | 2 | GO:0070553 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC6A4 ABCG4 ABCG1 SLC18A1 SLC22A5 SLC45A2 SLC35B2 SLC15A3 SLC39A8 SLC5A4 | 1.82e-05 | 477 | 79 | 10 | GO:0022804 |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 2.10e-05 | 14 | 79 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC6A4 SLC18A1 SLC22A5 SLC45A2 SLC35B2 SLC15A3 SLC39A8 SLC5A4 | 2.22e-05 | 296 | 79 | 8 | GO:0015291 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.99e-05 | 151 | 79 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 3.26e-05 | 46 | 79 | 4 | GO:0005245 | |
| GeneOntologyMolecularFunction | myosin heavy chain binding | 3.89e-05 | 17 | 79 | 3 | GO:0032036 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR1N1 OR2W3 HCAR3 HCAR2 OR4M2 OR2A7 OR2A4 OR52E4 ADGRG1 RGR OR6K6 OR4M2B OR4D2 | 4.04e-05 | 884 | 79 | 13 | GO:0004930 |
| GeneOntologyMolecularFunction | serotonin:sodium:chloride symporter activity | 4.62e-05 | 3 | 79 | 2 | GO:0005335 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 5.06e-05 | 431 | 79 | 9 | GO:0004984 | |
| GeneOntologyMolecularFunction | sodium channel activity | 5.32e-05 | 52 | 79 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | protein-cysteine S-palmitoyltransferase activity | 1.45e-04 | 26 | 79 | 3 | GO:0019706 | |
| GeneOntologyMolecularFunction | protein-cysteine S-acyltransferase activity | 1.45e-04 | 26 | 79 | 3 | GO:0019707 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 1.53e-04 | 5 | 79 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.71e-04 | 70 | 79 | 4 | GO:1901618 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity involved in cardiac muscle cell action potential | 2.29e-04 | 6 | 79 | 2 | GO:0086006 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 2.29e-04 | 6 | 79 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | alpha-actinin binding | 2.47e-04 | 31 | 79 | 3 | GO:0051393 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 3.26e-04 | 34 | 79 | 3 | GO:0042910 | |
| GeneOntologyMolecularFunction | gated channel activity | 3.56e-04 | 334 | 79 | 7 | GO:0022836 | |
| GeneOntologyMolecularFunction | palmitoyltransferase activity | 4.20e-04 | 37 | 79 | 3 | GO:0016409 | |
| GeneOntologyMolecularFunction | ATPase-coupled lipid transmembrane transporter activity | 5.46e-04 | 9 | 79 | 2 | GO:0034040 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 6.03e-04 | 172 | 79 | 5 | GO:0044325 | |
| GeneOntologyMolecularFunction | actinin binding | 6.56e-04 | 43 | 79 | 3 | GO:0042805 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 7.78e-04 | 182 | 79 | 5 | GO:0005244 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR1N1 OR2W3 HCAR3 HCAR2 OR4M2 OR2A7 OR2A4 OR52E4 ADGRG1 ITGAL RGR OR6K6 OR4M2B OR4D2 | 7.83e-04 | 1353 | 79 | 14 | GO:0004888 |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 8.17e-04 | 184 | 79 | 5 | GO:0022832 | |
| GeneOntologyMolecularFunction | monoamine transmembrane transporter activity | 9.94e-04 | 12 | 79 | 2 | GO:0008504 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 1.07e-03 | 293 | 79 | 6 | GO:0008514 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 1.23e-03 | 301 | 79 | 6 | GO:0022853 | |
| GeneOntologyMolecularFunction | floppase activity | 1.79e-03 | 16 | 79 | 2 | GO:0140328 | |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 2.02e-03 | 17 | 79 | 2 | GO:0005402 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 2.02e-03 | 17 | 79 | 2 | GO:0015378 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 2.27e-03 | 18 | 79 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 2.53e-03 | 19 | 79 | 2 | GO:0015373 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 3.04e-03 | 73 | 79 | 3 | GO:0170055 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 3.12e-03 | 152 | 79 | 4 | GO:0022843 | |
| GeneOntologyMolecularFunction | nucleotide receptor activity | 3.39e-03 | 22 | 79 | 2 | GO:0016502 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 3.39e-03 | 22 | 79 | 2 | GO:0050998 | |
| GeneOntologyMolecularFunction | purinergic nucleotide receptor activity | 3.39e-03 | 22 | 79 | 2 | GO:0001614 | |
| GeneOntologyMolecularFunction | ankyrin binding | 3.70e-03 | 23 | 79 | 2 | GO:0030506 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 3.70e-03 | 23 | 79 | 2 | GO:0015377 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYL12A SLC6A4 CACNA1C CACNA1D PPP2R2A MYL9 SCN5A LRRK2 PKD2 MACF1 MYL12B | 3.88e-03 | 1099 | 79 | 11 | GO:0008092 |
| GeneOntologyMolecularFunction | syntaxin-1 binding | 4.03e-03 | 24 | 79 | 2 | GO:0017075 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 4.07e-03 | 81 | 79 | 3 | GO:0015370 | |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 4.37e-03 | 25 | 79 | 2 | GO:0015149 | |
| GeneOntologyMolecularFunction | solute:proton symporter activity | 4.37e-03 | 25 | 79 | 2 | GO:0015295 | |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 4.37e-03 | 25 | 79 | 2 | GO:0055056 | |
| GeneOntologyMolecularFunction | myosin binding | 4.66e-03 | 85 | 79 | 3 | GO:0017022 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 4.72e-03 | 26 | 79 | 2 | GO:0015296 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 5.09e-03 | 27 | 79 | 2 | GO:0015145 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 5.47e-03 | 28 | 79 | 2 | GO:0140326 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 5.85e-03 | 29 | 79 | 2 | GO:0051119 | |
| GeneOntologyMolecularFunction | proton transmembrane transporter activity | 6.60e-03 | 188 | 79 | 4 | GO:0015078 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 6.67e-03 | 31 | 79 | 2 | GO:0099604 | |
| GeneOntologyMolecularFunction | protein phosphatase regulator activity | 7.32e-03 | 100 | 79 | 3 | GO:0019888 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 7.54e-03 | 33 | 79 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 7.63e-03 | 196 | 79 | 4 | GO:0005319 | |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell signaling | 9.15e-08 | 12 | 78 | 4 | GO:0086027 | |
| GeneOntologyBiologicalProcess | AV node cell action potential | 9.15e-08 | 12 | 78 | 4 | GO:0086016 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.25e-07 | 62 | 78 | 6 | GO:0086002 | |
| GeneOntologyBiologicalProcess | cell-cell signaling involved in cardiac conduction | 1.73e-07 | 34 | 78 | 5 | GO:0086019 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 2.34e-07 | 36 | 78 | 5 | GO:0086010 | |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell communication | 2.50e-07 | 15 | 78 | 4 | GO:0086067 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 3.76e-07 | 121 | 78 | 7 | GO:0051899 | |
| GeneOntologyBiologicalProcess | positive regulation of transport | ZDHHC2 SLC6A4 CACNA1C CACNA1D ABCG4 HCAR3 HCAR2 PLK2 ABCG1 SLC18A1 SCN5A LRRK2 SERPINE1 PKD2 APELA ZDHHC8 RYR2 | 4.53e-07 | 1081 | 78 | 17 | GO:0051050 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR1N1 OR2W3 CACNA1F OR4M2 OR2A7 OR2A4 PKD2 SCN10A OR52E4 RGR OR6K6 OR4M2B RYR2 OR4D2 | 4.70e-07 | 722 | 78 | 14 | GO:0051606 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 9.52e-07 | 87 | 78 | 6 | GO:0086001 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 1.41e-06 | 93 | 78 | 6 | GO:0086003 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC6A4 CACNA1C CACNA1D CACNA1F SLC18A1 SLC22A5 SCN4A SCN5A SERPINE1 PKD2 SCN10A ATP11C TMC5 SLC15A3 TMCO1 SLC39A8 RYR2 SLC5A4 | 2.74e-06 | 1374 | 78 | 18 | GO:0006811 |
| GeneOntologyBiologicalProcess | cell communication involved in cardiac conduction | 2.90e-06 | 59 | 78 | 5 | GO:0086065 | |
| GeneOntologyBiologicalProcess | regulation of membrane depolarization | 3.42e-06 | 61 | 78 | 5 | GO:0003254 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC6A4 CACNA1C CACNA1D CACNA1F SLC18A1 SCN4A SCN5A PKD2 SCN10A ATP11C TMC5 SLC15A3 TMCO1 SLC39A8 RYR2 SLC5A4 | 3.45e-06 | 1115 | 78 | 16 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC6A4 CACNA1C CACNA1D CACNA1F SLC18A1 SLC22A5 SCN4A SCN5A SERPINE1 PKD2 SCN10A SLC15A3 TMCO1 SLC39A8 RYR2 SLC5A4 | 5.52e-06 | 1157 | 78 | 16 | GO:0006812 |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell signaling | 6.12e-06 | 10 | 78 | 3 | GO:0086018 | |
| GeneOntologyBiologicalProcess | SA node cell action potential | 6.12e-06 | 10 | 78 | 3 | GO:0086015 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC6A4 CACNA1C CACNA1D CACNA1F SLC18A1 SCN4A SCN5A PKD2 SCN10A SLC15A3 TMCO1 SLC39A8 RYR2 SLC5A4 | 8.18e-06 | 922 | 78 | 14 | GO:0098662 |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell communication | 8.40e-06 | 11 | 78 | 3 | GO:0086070 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 8.65e-06 | 127 | 78 | 6 | GO:0070252 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC6A4 CACNA1C CACNA1D CACNA1F SLC18A1 SCN4A SCN5A PKD2 SCN10A SLC15A3 TMCO1 SLC39A8 RYR2 SLC5A4 | 1.04e-05 | 942 | 78 | 14 | GO:0098655 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR1N1 OR2W3 CACNA1F OR4M2 OR2A7 OR2A4 SCN10A OR52E4 OR6K6 OR4M2B OR4D2 | 1.15e-05 | 582 | 78 | 11 | GO:0050906 |
| GeneOntologyBiologicalProcess | metal ion transport | SLC6A4 CACNA1C CACNA1D CACNA1F SLC22A5 SCN4A SCN5A SERPINE1 PKD2 SCN10A TMCO1 SLC39A8 RYR2 SLC5A4 | 2.04e-05 | 1000 | 78 | 14 | GO:0030001 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC6A4 CACNA1C CACNA1D CACNA1F SLC18A1 SCN4A SCN5A PKD2 SCN10A SLC15A3 TMCO1 SLC39A8 RYR2 SLC5A4 | 2.45e-05 | 1017 | 78 | 14 | GO:0098660 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 2.50e-05 | 153 | 78 | 6 | GO:0030048 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR1N1 OR2W3 OR4M2 OR2A7 OR2A4 OR52E4 OR6K6 OR4M2B RYR2 OR4D2 | 2.75e-05 | 524 | 78 | 10 | GO:0009593 |
| GeneOntologyBiologicalProcess | calcium ion import | 3.50e-05 | 98 | 78 | 5 | GO:0070509 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | 3.63e-05 | 432 | 78 | 9 | GO:0050911 | |
| GeneOntologyBiologicalProcess | cardiac conduction | 3.86e-05 | 100 | 78 | 5 | GO:0061337 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 4.08e-05 | 167 | 78 | 6 | GO:0060048 | |
| GeneOntologyBiologicalProcess | membrane depolarization during atrial cardiac muscle cell action potential | 4.23e-05 | 3 | 78 | 2 | GO:0098912 | |
| GeneOntologyBiologicalProcess | sensory perception | OR1N1 OR2W3 CACNA1D CACNA1F OR4M2 OR2A7 OR2A4 SCN10A OR52E4 SLC45A2 RGR OR6K6 OR4M2B OR4D2 | 4.37e-05 | 1072 | 78 | 14 | GO:0007600 |
| GeneOntologyBiologicalProcess | import into cell | SLC6A4 CACNA1C CACNA1D CACNA1F PLK2 SLC18A1 SCN5A LRRK2 SERPINE1 ULK1 APELA SLC15A3 ITGAL SLC39A8 | 4.46e-05 | 1074 | 78 | 14 | GO:0098657 |
| GeneOntologyBiologicalProcess | regulation of membrane potential | SLC6A4 CACNA1C CACNA1D PLK2 SCN4A SCN5A LRRK2 SCN10A SLC39A8 RYR2 | 4.74e-05 | 559 | 78 | 10 | GO:0042391 |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell to AV node cell communication | 4.83e-05 | 19 | 78 | 3 | GO:0086066 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell to AV node cell signaling | 4.83e-05 | 19 | 78 | 3 | GO:0086026 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell action potential | 4.83e-05 | 19 | 78 | 3 | GO:0086014 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR1N1 OR2W3 CACNA1D HCAR3 HCAR2 OR4M2 OR2A7 OR2A4 LRRK2 OR52E4 ADGRG1 APELA RGR OR6K6 OR4M2B OR4D2 | 5.55e-05 | 1395 | 78 | 16 | GO:0007186 |
| GeneOntologyBiologicalProcess | regulation of striated muscle contraction | 6.37e-05 | 111 | 78 | 5 | GO:0006942 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | 6.40e-05 | 465 | 78 | 9 | GO:0007608 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transport | 6.64e-05 | 266 | 78 | 7 | GO:0043270 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 8.18e-05 | 275 | 78 | 7 | GO:0006814 | |
| GeneOntologyBiologicalProcess | positive regulation of adiponectin secretion | 8.43e-05 | 4 | 78 | 2 | GO:0070165 | |
| GeneOntologyBiologicalProcess | cellular response to high density lipoprotein particle stimulus | 8.43e-05 | 4 | 78 | 2 | GO:0071403 | |
| GeneOntologyBiologicalProcess | membrane depolarization during cardiac muscle cell action potential | 8.72e-05 | 23 | 78 | 3 | GO:0086012 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | 8.83e-05 | 485 | 78 | 9 | GO:0050907 | |
| GeneOntologyBiologicalProcess | regulation of system process | CACNA1C CACNA1D PLK2 MYL9 SLC22A5 SCN4A SCN5A LRRK2 SCN10A APELA RYR2 | 9.54e-05 | 734 | 78 | 11 | GO:0044057 |
| GeneOntologyBiologicalProcess | action potential | 1.14e-04 | 201 | 78 | 6 | GO:0001508 | |
| GeneOntologyBiologicalProcess | regulation of muscle contraction | 1.17e-04 | 202 | 78 | 6 | GO:0006937 | |
| GeneOntologyBiologicalProcess | regulation of heart rate | 1.30e-04 | 129 | 78 | 5 | GO:0002027 | |
| GeneOntologyBiologicalProcess | heart contraction | 1.35e-04 | 298 | 78 | 7 | GO:0060047 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 1.37e-04 | 208 | 78 | 6 | GO:0035725 | |
| GeneOntologyBiologicalProcess | membrane depolarization during SA node cell action potential | 1.40e-04 | 5 | 78 | 2 | GO:0086046 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 1.40e-04 | 5 | 78 | 2 | GO:1904879 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol efflux | 1.43e-04 | 27 | 78 | 3 | GO:0010875 | |
| GeneOntologyBiologicalProcess | heart process | 1.68e-04 | 309 | 78 | 7 | GO:0003015 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 1.73e-04 | 217 | 78 | 6 | GO:0006941 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 2.03e-04 | 142 | 78 | 5 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 2.03e-04 | 142 | 78 | 5 | GO:0098659 | |
| GeneOntologyBiologicalProcess | Purkinje myocyte to ventricular cardiac muscle cell communication | 2.10e-04 | 6 | 78 | 2 | GO:0086068 | |
| GeneOntologyBiologicalProcess | membrane depolarization during AV node cell action potential | 2.10e-04 | 6 | 78 | 2 | GO:0086045 | |
| GeneOntologyBiologicalProcess | Purkinje myocyte to ventricular cardiac muscle cell signaling | 2.10e-04 | 6 | 78 | 2 | GO:0086029 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | 2.18e-04 | 547 | 78 | 9 | GO:0007606 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 2.37e-04 | 230 | 78 | 6 | GO:0098739 | |
| GeneOntologyBiologicalProcess | protein palmitoylation | 2.62e-04 | 33 | 78 | 3 | GO:0018345 | |
| GeneOntologyBiologicalProcess | bundle of His cell action potential | 2.93e-04 | 7 | 78 | 2 | GO:0086043 | |
| GeneOntologyBiologicalProcess | bundle of His cell to Purkinje myocyte signaling | 2.93e-04 | 7 | 78 | 2 | GO:0086028 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport | 2.96e-04 | 154 | 78 | 5 | GO:0051928 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | SLC6A4 CACNA1C CACNA1D CACNA1F SCN5A SERPINE1 PKD2 SCN10A RYR2 | 3.23e-04 | 577 | 78 | 9 | GO:0043269 |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction | 3.62e-04 | 89 | 78 | 4 | GO:0055117 | |
| GeneOntologyBiologicalProcess | regulation of heart contraction | 3.62e-04 | 249 | 78 | 6 | GO:0008016 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle cell action potential | 3.68e-04 | 37 | 78 | 3 | GO:0086005 | |
| GeneOntologyBiologicalProcess | adiponectin secretion | 3.90e-04 | 8 | 78 | 2 | GO:0070162 | |
| GeneOntologyBiologicalProcess | regulation of adiponectin secretion | 3.90e-04 | 8 | 78 | 2 | GO:0070163 | |
| GeneOntologyBiologicalProcess | regulation of atrial cardiac muscle cell membrane repolarization | 3.90e-04 | 8 | 78 | 2 | GO:0060372 | |
| GeneOntologyBiologicalProcess | positive regulation of sterol transport | 4.65e-04 | 40 | 78 | 3 | GO:0032373 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol transport | 4.65e-04 | 40 | 78 | 3 | GO:0032376 | |
| GeneOntologyBiologicalProcess | regulation of heart rate by cardiac conduction | 5.00e-04 | 41 | 78 | 3 | GO:0086091 | |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | 5.14e-04 | 266 | 78 | 6 | GO:0019722 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell contraction | 5.76e-04 | 43 | 78 | 3 | GO:0086004 | |
| GeneOntologyBiologicalProcess | protein lipidation | 5.85e-04 | 101 | 78 | 4 | GO:0006497 | |
| GeneOntologyBiologicalProcess | regulation of atrial cardiac muscle cell membrane depolarization | 6.23e-04 | 10 | 78 | 2 | GO:0060371 | |
| GeneOntologyBiologicalProcess | lipoprotein biosynthetic process | 7.02e-04 | 106 | 78 | 4 | GO:0042158 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell membrane repolarization | 7.60e-04 | 11 | 78 | 2 | GO:0099624 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport | 7.79e-04 | 109 | 78 | 4 | GO:1904427 | |
| GeneOntologyBiologicalProcess | muscle contraction | 7.92e-04 | 400 | 78 | 7 | GO:0006936 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 7.96e-04 | 48 | 78 | 3 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 7.96e-04 | 48 | 78 | 3 | GO:1902656 | |
| GeneOntologyBiologicalProcess | positive regulation of secretion by cell | 8.40e-04 | 404 | 78 | 7 | GO:1903532 | |
| GeneOntologyBiologicalProcess | positive regulation of heart contraction | 8.46e-04 | 49 | 78 | 3 | GO:0045823 | |
| GeneOntologyBiologicalProcess | positive regulation of protein secretion | 8.47e-04 | 194 | 78 | 5 | GO:0050714 | |
| GeneOntologyBiologicalProcess | regulation of ventricular cardiac muscle cell action potential | 9.09e-04 | 12 | 78 | 2 | GO:0098911 | |
| GeneOntologyBiologicalProcess | manganese ion transmembrane transport | 9.09e-04 | 12 | 78 | 2 | GO:0071421 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transport | 1.01e-03 | 417 | 78 | 7 | GO:0034765 | |
| GeneOntologyBiologicalProcess | positive regulation of blood circulation | 1.06e-03 | 53 | 78 | 3 | GO:1903524 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based movement | 1.06e-03 | 53 | 78 | 3 | GO:1903115 | |
| GeneOntologyBiologicalProcess | positive regulation of hormone secretion | 1.08e-03 | 205 | 78 | 5 | GO:0046887 | |
| GeneOntologyBiologicalProcess | serotonin uptake | 1.25e-03 | 14 | 78 | 2 | GO:0051610 | |
| GeneOntologyBiologicalProcess | manganese ion transport | 1.25e-03 | 14 | 78 | 2 | GO:0006828 | |
| GeneOntologyCellularComponent | Z disc | 1.67e-06 | 151 | 79 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | recycling endosome | 1.95e-06 | 222 | 79 | 8 | GO:0055037 | |
| GeneOntologyCellularComponent | cation channel complex | 2.97e-06 | 235 | 79 | 8 | GO:0034703 | |
| GeneOntologyCellularComponent | I band | 3.15e-06 | 166 | 79 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 3.40e-05 | 17 | 79 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | protein phosphatase type 2A complex | 4.07e-05 | 18 | 79 | 3 | GO:0000159 | |
| GeneOntologyCellularComponent | sarcomere | 4.37e-05 | 249 | 79 | 7 | GO:0030017 | |
| GeneOntologyCellularComponent | myofibril | 7.80e-05 | 273 | 79 | 7 | GO:0030016 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | ZDHHC2 ABCG1 SLC18A1 DOLK LRRK2 PKD2 CYP2U1 ATP11C YIPF7 SLC35B2 ULK1 TMCO1 TLR8 OR6K6 RYR2 | 8.70e-05 | 1293 | 79 | 15 | GO:0005789 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 9.05e-05 | 378 | 79 | 8 | GO:0034702 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | ZDHHC2 ABCG1 SLC18A1 DOLK LRRK2 PKD2 CYP2U1 ATP11C YIPF7 SLC35B2 ULK1 TMCO1 TLR8 OR6K6 RYR2 | 9.16e-05 | 1299 | 79 | 15 | GO:0098827 |
| GeneOntologyCellularComponent | endosome | ZDHHC2 SLC6A4 CMTM6 ABCG4 ABCG1 OR2A7 ARHGAP10 OR2A4 LRRK2 ATP11C ULK1 SLC15A3 DENND2B TLR8 | 1.09e-04 | 1167 | 79 | 14 | GO:0005768 |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.14e-04 | 290 | 79 | 7 | GO:0043292 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | ZDHHC2 ABCG1 SLC18A1 DOLK LRRK2 PKD2 CYP2U1 ATP11C YIPF7 SLC35B2 ULK1 TMCO1 TLR8 OR6K6 RYR2 | 1.16e-04 | 1327 | 79 | 15 | GO:0042175 |
| GeneOntologyCellularComponent | myosin II complex | 1.59e-04 | 28 | 79 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.69e-04 | 73 | 79 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.77e-04 | 29 | 79 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | transporter complex | 2.27e-04 | 550 | 79 | 9 | GO:1990351 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | ZDHHC2 SLC6A4 CMTM6 ABCG4 SLC18A1 ARHGAP10 LRRK2 PKD2 ATP11C SLC45A2 ULK1 SLC15A3 ITGAL TLR8 | 3.52e-04 | 1307 | 79 | 14 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | ZDHHC2 SLC6A4 CMTM6 ABCG4 SLC18A1 ARHGAP10 LRRK2 PKD2 ATP11C SLC45A2 ULK1 SLC15A3 ITGAL TLR8 | 4.04e-04 | 1325 | 79 | 14 | GO:0012506 |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 7.01e-04 | 46 | 79 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 8.00e-04 | 523 | 79 | 8 | GO:1902495 | |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 9.08e-04 | 12 | 79 | 2 | GO:1990454 | |
| GeneOntologyCellularComponent | phosphatase complex | 1.18e-03 | 55 | 79 | 3 | GO:1903293 | |
| GeneOntologyCellularComponent | protein serine/threonine phosphatase complex | 1.18e-03 | 55 | 79 | 3 | GO:0008287 | |
| GeneOntologyCellularComponent | myosin complex | 1.45e-03 | 59 | 79 | 3 | GO:0016459 | |
| GeneOntologyCellularComponent | Golgi membrane | ZDHHC2 ABCG1 LRRK2 ZDHHC5 B4GALNT2 SLC35B2 TMCO1 ZDHHC8 TLR8 | 1.57e-03 | 721 | 79 | 9 | GO:0000139 |
| GeneOntologyCellularComponent | mitotic spindle midzone | 1.64e-03 | 16 | 79 | 2 | GO:1990023 | |
| GeneOntologyCellularComponent | endosome membrane | 1.96e-03 | 602 | 79 | 8 | GO:0010008 | |
| GeneOntologyCellularComponent | cell cortex | 2.81e-03 | 371 | 79 | 6 | GO:0005938 | |
| GeneOntologyCellularComponent | vacuolar membrane | 3.05e-03 | 507 | 79 | 7 | GO:0005774 | |
| GeneOntologyCellularComponent | T-tubule | 3.34e-03 | 79 | 79 | 3 | GO:0030315 | |
| HumanPheno | Hypokalemia | 2.62e-06 | 79 | 27 | 6 | HP:0002900 | |
| HumanPheno | Torsade de pointes | 7.34e-06 | 25 | 27 | 4 | HP:0001664 | |
| HumanPheno | Bradycardia | 9.28e-06 | 98 | 27 | 6 | HP:0001662 | |
| HumanPheno | Sick sinus syndrome | 1.36e-05 | 29 | 27 | 4 | HP:0011704 | |
| HumanPheno | Abnormal blood potassium concentration | 2.11e-05 | 113 | 27 | 6 | HP:0011042 | |
| HumanPheno | Atrioventricular block | 1.07e-04 | 93 | 27 | 5 | HP:0001678 | |
| HumanPheno | Heart block | 1.07e-04 | 93 | 27 | 5 | HP:0001668 | |
| HumanPheno | Abnormal blood monovalent inorganic cation concentration | 1.21e-04 | 154 | 27 | 6 | HP:0010930 | |
| HumanPheno | Abnormal cardiac exercise stress test | 1.22e-04 | 19 | 27 | 3 | HP:0500018 | |
| HumanPheno | Aborted sudden cardiac death | 1.61e-04 | 4 | 27 | 2 | HP:0031628 | |
| HumanPheno | Trifascicular block | 1.91e-04 | 22 | 27 | 3 | HP:0011715 | |
| HumanPheno | Reduced systolic function | 2.19e-04 | 23 | 27 | 3 | HP:0006673 | |
| HumanPheno | ST segment elevation | 2.83e-04 | 25 | 27 | 3 | HP:0012251 | |
| HumanPheno | Ventricular fibrillation | 3.01e-04 | 63 | 27 | 4 | HP:0001663 | |
| HumanPheno | Paroxysmal ventricular tachycardia | 3.57e-04 | 27 | 27 | 3 | HP:0004751 | |
| HumanPheno | Syncope | 3.70e-04 | 121 | 27 | 5 | HP:0001279 | |
| HumanPheno | Atrial standstill | 4.01e-04 | 6 | 27 | 2 | HP:0025478 | |
| HumanPheno | Ventricular tachycardia | 4.28e-04 | 69 | 27 | 4 | HP:0004756 | |
| HumanPheno | Prolonged QTc interval | 4.43e-04 | 29 | 27 | 3 | HP:0005184 | |
| HumanPheno | Sinus bradycardia | 4.90e-04 | 30 | 27 | 3 | HP:0001688 | |
| HumanPheno | Abnormal atrioventricular conduction | 5.34e-04 | 131 | 27 | 5 | HP:0005150 | |
| HumanPheno | Atrioventricular nodal disease | 5.34e-04 | 131 | 27 | 5 | HP:0005142 | |
| HumanPheno | Heart block | 6.34e-04 | 136 | 27 | 5 | HP:0012722 | |
| MousePheno | atrial fibrillation | 7.56e-06 | 10 | 57 | 3 | MP:0008543 | |
| MousePheno | abnormal action potential | 1.61e-05 | 133 | 57 | 6 | MP:0005402 | |
| MousePheno | fibrillation | 2.27e-05 | 14 | 57 | 3 | MP:0006109 | |
| MousePheno | sinus bradycardia | 2.27e-05 | 14 | 57 | 3 | MP:0010637 | |
| MousePheno | abnormal myocardial fiber sodium currents | 4.89e-05 | 3 | 57 | 2 | MP:0020347 | |
| Domain | Channel_four-helix_dom | 2.59e-09 | 57 | 74 | 7 | IPR027359 | |
| Domain | - | 2.59e-09 | 57 | 74 | 7 | 1.20.120.350 | |
| Domain | MFS_dom | SLC18A1 SLC22A14 MFSD11 SLC22A5 SLC49A4 SLC45A2 SLC43A3 SLC15A3 | 5.76e-08 | 134 | 74 | 8 | IPR020846 |
| Domain | CAC1F_C | 5.97e-08 | 3 | 74 | 3 | IPR031688 | |
| Domain | CAC1F_C | 5.97e-08 | 3 | 74 | 3 | PF16885 | |
| Domain | PP2A_PR55 | 2.38e-07 | 4 | 74 | 3 | IPR000009 | |
| Domain | PP2A_PR55_CS | 2.38e-07 | 4 | 74 | 3 | IPR018067 | |
| Domain | VDCC_L_a1su | 2.38e-07 | 4 | 74 | 3 | IPR005446 | |
| Domain | PR55_2 | 2.38e-07 | 4 | 74 | 3 | PS01025 | |
| Domain | PR55_1 | 2.38e-07 | 4 | 74 | 3 | PS01024 | |
| Domain | Ion_trans_dom | 3.37e-07 | 114 | 74 | 7 | IPR005821 | |
| Domain | Ion_trans | 3.37e-07 | 114 | 74 | 7 | PF00520 | |
| Domain | VDCC_a1su_IQ | 2.07e-06 | 7 | 74 | 3 | IPR014873 | |
| Domain | GPHH | 2.07e-06 | 7 | 74 | 3 | PF16905 | |
| Domain | GPHH_dom | 2.07e-06 | 7 | 74 | 3 | IPR031649 | |
| Domain | Ca_chan_IQ | 2.07e-06 | 7 | 74 | 3 | SM01062 | |
| Domain | Ca_chan_IQ | 2.07e-06 | 7 | 74 | 3 | PF08763 | |
| Domain | Na_channel_asu | 7.02e-06 | 10 | 74 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 7.02e-06 | 10 | 74 | 3 | IPR010526 | |
| Domain | VDCCAlpha1 | 7.02e-06 | 10 | 74 | 3 | IPR002077 | |
| Domain | Na_trans_assoc | 7.02e-06 | 10 | 74 | 3 | PF06512 | |
| Domain | ABCG1 | 1.55e-05 | 2 | 74 | 2 | IPR020064 | |
| Domain | HCAR2/3_rcpt | 1.55e-05 | 2 | 74 | 2 | IPR028017 | |
| Domain | EF-hand-dom_pair | 1.77e-05 | 287 | 74 | 8 | IPR011992 | |
| Domain | EF_hand_DJBP | 4.63e-05 | 3 | 74 | 2 | IPR015070 | |
| Domain | EF-hand_11 | 4.63e-05 | 3 | 74 | 2 | PF08976 | |
| Domain | GPCR_Rhodpsn_7TM | OR1N1 OR2W3 HCAR3 HCAR2 OR4M2 OR2A7 OR2A4 OR52E4 RGR OR6K6 OR4D2 | 6.24e-05 | 670 | 74 | 11 | IPR017452 |
| Domain | 7tm_1 | OR1N1 OR2W3 HCAR3 HCAR2 OR4M2 OR2A7 OR2A4 OR52E4 RGR OR6K6 OR4D2 | 6.84e-05 | 677 | 74 | 11 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR1N1 OR2W3 HCAR3 HCAR2 OR4M2 OR2A7 OR2A4 OR52E4 RGR OR6K6 OR4D2 | 7.60e-05 | 685 | 74 | 11 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR1N1 OR2W3 HCAR3 HCAR2 OR4M2 OR2A7 OR2A4 OR52E4 RGR OR6K6 OR4D2 | 8.22e-05 | 691 | 74 | 11 | PS50262 |
| Domain | GPCR_Rhodpsn | OR1N1 OR2W3 HCAR3 HCAR2 OR4M2 OR2A7 OR2A4 OR52E4 RGR OR6K6 OR4D2 | 8.32e-05 | 692 | 74 | 11 | IPR000276 |
| Domain | zf-DHHC | 9.99e-05 | 23 | 74 | 3 | PF01529 | |
| Domain | DHHC | 1.29e-04 | 25 | 74 | 3 | PS50216 | |
| Domain | Znf_DHHC_palmitoyltrfase | 1.29e-04 | 25 | 74 | 3 | IPR001594 | |
| Domain | ABC_2_trans | 1.54e-04 | 5 | 74 | 2 | IPR013525 | |
| Domain | ABC2_membrane | 1.54e-04 | 5 | 74 | 2 | PF01061 | |
| Domain | Olfact_rcpt | 1.61e-04 | 393 | 74 | 8 | IPR000725 | |
| Domain | MFS_1 | 2.47e-04 | 77 | 74 | 4 | PF07690 | |
| Domain | MFS | 2.47e-04 | 77 | 74 | 4 | IPR011701 | |
| Domain | EF_HAND_2 | 3.08e-04 | 231 | 74 | 6 | PS50222 | |
| Domain | EF_hand_dom | 3.15e-04 | 232 | 74 | 6 | IPR002048 | |
| Domain | EF-hand_1 | 3.43e-04 | 152 | 74 | 5 | PF00036 | |
| Domain | EFh | 4.09e-04 | 158 | 74 | 5 | SM00054 | |
| Domain | - | 5.88e-04 | 261 | 74 | 6 | 1.10.238.10 | |
| Domain | MFS | 8.91e-04 | 108 | 74 | 4 | PS50850 | |
| Domain | EF-hand_6 | 1.17e-03 | 13 | 74 | 2 | PF13405 | |
| Domain | EF_HAND_1 | 1.29e-03 | 204 | 74 | 5 | PS00018 | |
| Domain | Aa_trans | 2.03e-03 | 17 | 74 | 2 | PF01490 | |
| Domain | AA_transpt_TM | 2.03e-03 | 17 | 74 | 2 | IPR013057 | |
| Domain | EF_Hand_1_Ca_BS | 5.15e-03 | 175 | 74 | 4 | IPR018247 | |
| Domain | IQ_motif_EF-hand-BS | 5.48e-03 | 90 | 74 | 3 | IPR000048 | |
| Domain | IQ | 6.00e-03 | 93 | 74 | 3 | PS50096 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 1.45e-06 | 6 | 60 | 3 | M47762 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 2.17e-06 | 203 | 60 | 8 | M5485 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_RHOA_SIGNALING_PATHWAY | 8.61e-06 | 10 | 60 | 3 | M47739 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 9.75e-06 | 32 | 60 | 4 | M27455 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAA_TO_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 1.18e-05 | 11 | 60 | 3 | M47721 | |
| Pathway | KEGG_TIGHT_JUNCTION | 1.99e-05 | 132 | 60 | 6 | M11355 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 2.58e-05 | 14 | 60 | 3 | M47692 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY | 6.77e-05 | 19 | 60 | 3 | M47525 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY | 1.07e-04 | 22 | 60 | 3 | M47919 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCG4 ABCG1 SLC18A1 SLC22A5 ATP11C SLC35B2 SLC15A3 ZDHHC8 SLC39A8 RYR2 SLC5A4 | 1.21e-04 | 681 | 60 | 11 | MM14985 |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 1.22e-04 | 23 | 60 | 3 | M47666 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 1.22e-04 | 23 | 60 | 3 | MM15222 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 1.58e-04 | 25 | 60 | 3 | M47948 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.25e-04 | 130 | 60 | 5 | M27454 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | 2.28e-04 | 389 | 60 | 8 | M14091 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCG4 ABCG1 SLC18A1 SLC22A5 ATP11C SLC35B2 SLC15A3 ZDHHC8 SLC39A8 RYR2 SLC5A4 | 2.39e-04 | 736 | 60 | 11 | M27287 |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 2.73e-04 | 74 | 60 | 4 | M39462 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 2.73e-04 | 74 | 60 | 4 | M16376 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 3.03e-04 | 31 | 60 | 3 | M877 | |
| Pathway | KEGG_CARDIAC_MUSCLE_CONTRACTION | 3.51e-04 | 79 | 60 | 4 | M17673 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 3.64e-04 | 417 | 60 | 8 | M4072 | |
| Pathway | WP_GLYCOGEN_METABOLISM | 3.99e-04 | 34 | 60 | 3 | MM15985 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 4.24e-04 | 83 | 60 | 4 | M8728 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 4.35e-04 | 35 | 60 | 3 | MM15114 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 5.08e-04 | 238 | 60 | 6 | MM15076 | |
| Pathway | REACTOME_MATURATION_OF_SPIKE_PROTEIN | 5.14e-04 | 37 | 60 | 3 | M41728 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 5.77e-04 | 90 | 60 | 4 | M835 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 6.45e-04 | 249 | 60 | 6 | M5988 | |
| Pathway | WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION | 6.47e-04 | 40 | 60 | 3 | M39595 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 6.72e-04 | 165 | 60 | 5 | MM15026 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 8.01e-04 | 43 | 60 | 3 | M1429 | |
| Pathway | WP_WNT_SIGNALING_AND_PLURIPOTENCY | 8.90e-04 | 101 | 60 | 4 | M39387 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 9.02e-04 | 367 | 60 | 7 | M48346 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 9.56e-04 | 11 | 60 | 2 | M47958 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 1.38e-03 | 636 | 60 | 9 | M41834 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 1.44e-03 | 115 | 60 | 4 | M9387 | |
| Pathway | KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION | 1.49e-03 | 116 | 60 | 4 | M2164 | |
| Pathway | REACTOME_TRANSLATION_OF_SARS_COV_2_STRUCTURAL_PROTEINS | 1.82e-03 | 57 | 60 | 3 | M41730 | |
| Pathway | WP_SIDS_SUSCEPTIBILITY_PATHWAYS | 2.01e-03 | 59 | 60 | 3 | MM15838 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 2.33e-03 | 17 | 60 | 2 | MM14552 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 2.61e-03 | 18 | 60 | 2 | M524 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 2.88e-03 | 575 | 60 | 8 | M29853 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 2.91e-03 | 19 | 60 | 2 | M27493 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_CIT | 2.91e-03 | 19 | 60 | 2 | M27489 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 3.22e-03 | 20 | 60 | 2 | M18415 | |
| Pathway | REACTOME_LATE_SARS_COV_2_INFECTION_EVENTS | 3.28e-03 | 70 | 60 | 3 | M46438 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 3.55e-03 | 21 | 60 | 2 | M27494 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CARDIAC_TYPE_VGCC_RYR_SIGNALING | 3.55e-03 | 21 | 60 | 2 | M47950 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 3.83e-03 | 74 | 60 | 3 | MM15962 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 4.13e-03 | 76 | 60 | 3 | MM15072 | |
| Pubmed | 1.17e-08 | 3 | 80 | 3 | 11942626 | ||
| Pubmed | 1.17e-08 | 3 | 80 | 3 | 9514514 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 3.48e-08 | 139 | 80 | 7 | 16985003 | |
| Pubmed | 4.68e-08 | 4 | 80 | 3 | 20937870 | ||
| Pubmed | Mouse myosin-19 is a plus-end-directed, high-duty ratio molecular motor. | 4.68e-08 | 4 | 80 | 3 | 24825904 | |
| Pubmed | 1.17e-07 | 5 | 80 | 3 | 15578586 | ||
| Pubmed | 1.17e-07 | 5 | 80 | 3 | 31663850 | ||
| Pubmed | 4.07e-07 | 7 | 80 | 3 | 21126233 | ||
| Pubmed | 4.07e-07 | 7 | 80 | 3 | 8207020 | ||
| Pubmed | HSF1 transcriptional activity is modulated by IER5 and PP2A/B55. | 4.07e-07 | 7 | 80 | 3 | 25816751 | |
| Pubmed | 4.07e-07 | 7 | 80 | 3 | 12900400 | ||
| Pubmed | 6.51e-07 | 8 | 80 | 3 | 15638722 | ||
| Pubmed | 6.51e-07 | 8 | 80 | 3 | 33424621 | ||
| Pubmed | 9.75e-07 | 9 | 80 | 3 | 16382098 | ||
| Pubmed | 9.75e-07 | 9 | 80 | 3 | 19762425 | ||
| Pubmed | 1.29e-06 | 343 | 80 | 8 | 32295537 | ||
| Pubmed | 1.38e-06 | 346 | 80 | 8 | 14611657 | ||
| Pubmed | 1.39e-06 | 10 | 80 | 3 | 26897459 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.80e-06 | 38 | 80 | 4 | 30786075 | |
| Pubmed | 1.91e-06 | 11 | 80 | 3 | 9171826 | ||
| Pubmed | 1.91e-06 | 11 | 80 | 3 | 18809727 | ||
| Pubmed | 3.30e-06 | 13 | 80 | 3 | 18971272 | ||
| Pubmed | 4.19e-06 | 14 | 80 | 3 | 9400615 | ||
| Pubmed | 4.19e-06 | 14 | 80 | 3 | 16048649 | ||
| Pubmed | Direct activation of protein phosphatase-2A0 by HIV-1 encoded protein complex NCp7:vpr. | 4.19e-06 | 14 | 80 | 3 | 9013886 | |
| Pubmed | A common genetic variant within SCN10A modulates cardiac SCN5A expression. | 5.23e-06 | 2 | 80 | 2 | 24642470 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 15240127 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 28186140 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 30154797 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 23723061 | ||
| Pubmed | The role of HCA2 (GPR109A) in regulating macrophage function. | 5.23e-06 | 2 | 80 | 2 | 23882124 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 36891315 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 24244166 | ||
| Pubmed | Parabacteroides distasonis ameliorates insulin resistance via activation of intestinal GPR109a. | 5.23e-06 | 2 | 80 | 2 | 38007572 | |
| Pubmed | Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE. | 5.23e-06 | 2 | 80 | 2 | 24691444 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 31347703 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 15047701 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 21054386 | ||
| Pubmed | Loss of GPR109A/HCAR2 induces aging-associated hepatic steatosis. | 5.23e-06 | 2 | 80 | 2 | 30659164 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 20381161 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 37373335 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 19223991 | ||
| Pubmed | Niacin increases adiponectin and decreases adipose tissue inflammation in high fat diet-fed mice. | 5.23e-06 | 2 | 80 | 2 | 23967184 | |
| Pubmed | Voltage-Gated Cav1 Channels in Disorders of Vision and Hearing. | 5.23e-06 | 2 | 80 | 2 | 25966695 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 26371038 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 34653248 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 19136666 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 33488584 | ||
| Pubmed | Lactate-induced activation of HCA2 improves survival in mice with sepsis. | 5.23e-06 | 2 | 80 | 2 | 30951370 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 24086669 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 31858105 | ||
| Pubmed | Exploring the role of the metabolite-sensing receptor GPR109a in diabetic nephropathy. | 5.23e-06 | 2 | 80 | 2 | 32068460 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 30657794 | ||
| Pubmed | Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3. | 5.23e-06 | 2 | 80 | 2 | 26049024 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 34092246 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 11834499 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 19225208 | ||
| Pubmed | Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. | 5.23e-06 | 2 | 80 | 2 | 16706838 | |
| Pubmed | Molecular identification of high and low affinity receptors for nicotinic acid. | 5.23e-06 | 2 | 80 | 2 | 12522134 | |
| Pubmed | Identification of protein phosphatase 2A as an interacting protein of leucine-rich repeat kinase 2. | 5.23e-06 | 2 | 80 | 2 | 26894577 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 23761887 | ||
| Pubmed | Regulation of ryanodine receptor-dependent calcium signaling by polycystin-2. | 5.23e-06 | 2 | 80 | 2 | 17404231 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 14981074 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 25049274 | ||
| Pubmed | CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum. | 5.23e-06 | 2 | 80 | 2 | 25292336 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 30271409 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 17526649 | ||
| Pubmed | Niacin fine-tunes energy homeostasis through canonical GPR109A signaling. | 5.23e-06 | 2 | 80 | 2 | 30596513 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 35320002 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 12606379 | ||
| Pubmed | GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing. | 5.23e-06 | 2 | 80 | 2 | 16322797 | |
| Pubmed | Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators. | 5.23e-06 | 2 | 80 | 2 | 24941892 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 18983141 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 31366236 | ||
| Pubmed | Complex Brugada syndrome inheritance in a family harbouring compound SCN5A and CACNA1C mutations. | 5.23e-06 | 2 | 80 | 2 | 25341504 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 22826131 | ||
| Pubmed | C-terminal modulator controls Ca2+-dependent gating of Ca(v)1.4 L-type Ca2+ channels. | 5.23e-06 | 2 | 80 | 2 | 16921373 | |
| Pubmed | Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome. | 5.23e-06 | 2 | 80 | 2 | 24998131 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 24470632 | ||
| Pubmed | GPR109A gene deletion ameliorates gonadectomy-induced bone loss in mice. | 5.23e-06 | 2 | 80 | 2 | 35489706 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 16319503 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 24360055 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 26823757 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 24760982 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 19561068 | ||
| Pubmed | Purkinje Cells as Sources of Arrhythmias in Long QT Syndrome Type 3. | 5.23e-06 | 2 | 80 | 2 | 26289036 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 32330377 | ||
| Pubmed | Maurocalcin and its analog MCaE12A facilitate Ca2+ mobilization in cardiomyocytes. | 5.23e-06 | 2 | 80 | 2 | 33034621 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 20014384 | ||
| Pubmed | The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival. | 5.23e-06 | 2 | 80 | 2 | 24371223 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 27228027 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 21774590 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 30001160 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 21352396 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 36208084 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 26656756 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 15932895 | ||
| Pubmed | Biased allosteric activation of ketone body receptor HCAR2 suppresses inflammation. | 5.23e-06 | 2 | 80 | 2 | 37597514 | |
| Pubmed | The Role of GPR109a Signaling in Niacin Induced Effects on Fed and Fasted Hepatic Metabolism. | 5.23e-06 | 2 | 80 | 2 | 33924461 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 33977048 | ||
| Interaction | CACNA1D interactions | 1.52e-08 | 24 | 68 | 5 | int:CACNA1D | |
| Interaction | SCN11A interactions | 1.57e-07 | 15 | 68 | 4 | int:SCN11A | |
| Interaction | SCN1A interactions | 2.64e-06 | 29 | 68 | 4 | int:SCN1A | |
| Interaction | PABIR1 interactions | 3.48e-06 | 31 | 68 | 4 | int:PABIR1 | |
| Interaction | SCN10A interactions | 5.95e-06 | 11 | 68 | 3 | int:SCN10A | |
| Interaction | IER5 interactions | 1.03e-05 | 13 | 68 | 3 | int:IER5 | |
| Interaction | SCN5A interactions | 1.90e-05 | 47 | 68 | 4 | int:SCN5A | |
| Interaction | SNTA1 interactions | 2.80e-05 | 105 | 68 | 5 | int:SNTA1 | |
| Interaction | SYNGR1 interactions | 3.35e-05 | 109 | 68 | 5 | int:SYNGR1 | |
| Interaction | SERTAD4 interactions | 3.43e-05 | 19 | 68 | 3 | int:SERTAD4 | |
| Interaction | TSPAN15 interactions | 3.98e-05 | 276 | 68 | 7 | int:TSPAN15 | |
| Interaction | SCN9A interactions | 4.68e-05 | 21 | 68 | 3 | int:SCN9A | |
| Interaction | CACNA1C interactions | 5.35e-05 | 61 | 68 | 4 | int:CACNA1C | |
| Interaction | RBM7 interactions | 6.71e-05 | 126 | 68 | 5 | int:RBM7 | |
| Interaction | MYL9 interactions | 7.74e-05 | 67 | 68 | 4 | int:MYL9 | |
| Interaction | CLDND1 interactions | 9.19e-05 | 70 | 68 | 4 | int:CLDND1 | |
| Interaction | MYL12B interactions | 1.03e-04 | 138 | 68 | 5 | int:MYL12B | |
| Interaction | FOXD3 interactions | 1.13e-04 | 28 | 68 | 3 | int:FOXD3 | |
| Interaction | ATP13A3 interactions | 1.35e-04 | 146 | 68 | 5 | int:ATP13A3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p22 | 3.11e-04 | 184 | 80 | 4 | chr3p22 | |
| GeneFamily | Solute carriers | SLC6A4 SLC38A10 SLC18A1 SLC22A14 SLC22A5 SLC49A4 SLC45A2 SLC35B2 SLC43A3 SLC15A3 SLC38A6 SLC39A8 SLC5A4 | 1.52e-09 | 395 | 66 | 13 | 752 |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 3.84e-06 | 9 | 66 | 3 | 1203 | |
| GeneFamily | Myosin light chains|EF-hand domain containing | 1.64e-05 | 14 | 66 | 3 | 657 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 2.05e-05 | 15 | 66 | 3 | 696 | |
| GeneFamily | Hydroxy-carboxylic acid receptors | 3.93e-05 | 3 | 66 | 2 | 200 | |
| GeneFamily | Zinc fingers DHHC-type|Ankyrin repeat domain containing | 8.90e-05 | 24 | 66 | 3 | 76 | |
| GeneFamily | Calcium voltage-gated channel subunits | 1.14e-04 | 26 | 66 | 3 | 253 | |
| GeneFamily | Blood group antigens|CD molecules|ATP binding cassette subfamily G | 1.30e-04 | 5 | 66 | 2 | 811 | |
| GeneFamily | EF-hand domain containing | 1.46e-04 | 219 | 66 | 6 | 863 | |
| GeneFamily | Olfactory receptors, family 2 | 8.17e-03 | 113 | 66 | 3 | 149 | |
| Coexpression | SWEET_KRAS_TARGETS_UP | 1.66e-07 | 83 | 77 | 6 | M2448 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.44e-07 | 162 | 79 | 6 | 60d3fe1f5cec4285b8774ff078ebcc6bfaec26ed | |
| ToppCell | E18.5-samps-Myeloid|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.44e-07 | 162 | 79 | 6 | 18e4a807e25f754a69e9eaaddfde40f8de9b8512 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.44e-07 | 162 | 79 | 6 | 0970e4eda60e3f015335e2726e6d565fb2f43372 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD8-Tem/emra_CD8|blood / Manually curated celltypes from each tissue | 1.13e-06 | 190 | 79 | 6 | 5624f711b34132081f93fa70702316962e3e3c64 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.31e-06 | 195 | 79 | 6 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-06 | 197 | 79 | 6 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.39e-06 | 197 | 79 | 6 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-05 | 172 | 79 | 5 | c8ea80042faf923b08ff03d73100533d521d73ef | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 172 | 79 | 5 | cfcfa7eeff1805bedf10a3c07826459914c3e872 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.54e-05 | 176 | 79 | 5 | 8e7f38de8bf68077e2138f4d06c1f55b0fd096cc | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.54e-05 | 176 | 79 | 5 | ed575330a08a6748ea4b28433292c8cfd157d444 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.72e-05 | 180 | 79 | 5 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-05 | 184 | 79 | 5 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 186 | 79 | 5 | 75258d88e23112fd1f0f7c71ef0366abb400d33e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-05 | 186 | 79 | 5 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD8+_T_activated|COVID-19_Severe / Disease group, lineage and cell class | 2.07e-05 | 187 | 79 | 5 | 4c4c4406e16a15dedcd50bbcc2059d722a2e3d2c | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.07e-05 | 187 | 79 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 2.12e-05 | 188 | 79 | 5 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 2.12e-05 | 188 | 79 | 5 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.17e-05 | 189 | 79 | 5 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.23e-05 | 190 | 79 | 5 | b9182c84e44aa31684b5388cf3ef4fd1b9e51de4 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.23e-05 | 190 | 79 | 5 | 88c092a5e78ccaddf406f8fff74376bb761b9790 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.23e-05 | 190 | 79 | 5 | 4b42a16902d7d1494f953cc88af1e761e76bdf2c | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.23e-05 | 190 | 79 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.23e-05 | 190 | 79 | 5 | 9501f0995f3d52be90c02b1aa0c7d184bd788c16 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Tem/emra_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.23e-05 | 190 | 79 | 5 | 66d29f53f129fc18771f6214316a913eeaccd55e | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD8-Tem/emra_CD8|bone_marrow / Manually curated celltypes from each tissue | 2.29e-05 | 191 | 79 | 5 | db7b8f8826bf19d6eeee14319570a9e6e99ab2cb | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.29e-05 | 191 | 79 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.34e-05 | 192 | 79 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.34e-05 | 192 | 79 | 5 | d9e27b8c2fd64e318a399feb5a51283616e1a30c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.40e-05 | 193 | 79 | 5 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.40e-05 | 193 | 79 | 5 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.40e-05 | 193 | 79 | 5 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.40e-05 | 193 | 79 | 5 | 3184a5f454e3ac5a81f6bacf9bd8f07d9d448fba | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Cytotoxic_CD8+_T|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.46e-05 | 194 | 79 | 5 | 73c057b623829de793616d9d373a0018071d51d8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.46e-05 | 194 | 79 | 5 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.46e-05 | 194 | 79 | 5 | 24837a27b0041fe8c348225fa8b09b127d743603 | |
| ToppCell | BLOOD--(1)_EM_CTLs| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.46e-05 | 194 | 79 | 5 | 66583c6cff3814902d6babdea3a2ae962decde65 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_memory_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.46e-05 | 194 | 79 | 5 | 866a9ca4c93c3c79c709a9d00def5392197f7e18 | |
| ToppCell | T/NK_cells-NKT_cell|World / Lineage and Cell class | 2.46e-05 | 194 | 79 | 5 | 8e09989ec2d1bbfe70cb18321c2ae94e0d0d9f18 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-CD8_TEM|Multiple_Sclerosis / Disease, Lineage and Cell Type | 2.46e-05 | 194 | 79 | 5 | fa53f1aab2f5923e90f090e10e3560b583441dc4 | |
| ToppCell | severe-CD8+_Tem|severe / disease stage, cell group and cell class | 2.59e-05 | 196 | 79 | 5 | 9456a5879948e25bc483a7233c274da841ef2c68 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.59e-05 | 196 | 79 | 5 | c100967851f037b3522130a9e2a4175ad593ecbc | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.59e-05 | 196 | 79 | 5 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | ASK452-Epithelial-Transformed_epithelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.65e-05 | 197 | 79 | 5 | b22a79a5922c865a360e2afc5506a08a512fa76a | |
| ToppCell | ASK452-Epithelial-Transformed_epithelium|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.65e-05 | 197 | 79 | 5 | e92757e988888347c74286cc42c262b03159b0b9 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.65e-05 | 197 | 79 | 5 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.72e-05 | 198 | 79 | 5 | a6b942fe850e287e1cb705684e29218072daf891 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.72e-05 | 198 | 79 | 5 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.72e-05 | 198 | 79 | 5 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.78e-05 | 199 | 79 | 5 | 63e632b06e13d2bcde5a00a51962bafdf60fd6c6 | |
| ToppCell | COVID-19_Moderate-CD8+_Tem|COVID-19_Moderate / disease group, cell group and cell class | 2.78e-05 | 199 | 79 | 5 | adcaf9bd73933259dcf7983ca369a98e2f312d0b | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.78e-05 | 199 | 79 | 5 | fbbac5e9153e813db848d498eb715aa208568d8d | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.85e-05 | 200 | 79 | 5 | af43f6d0e03b77f5eca1762e7b2be1d244d47664 | |
| ToppCell | remission-CD8+_Tem|World / disease stage, cell group and cell class | 2.85e-05 | 200 | 79 | 5 | 0ebf0dda91fc7adb9ea69734ad9dcc65d0082c6d | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.85e-05 | 200 | 79 | 5 | 63077e1f801f1c08bd339f5517f5781da240c04f | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.85e-05 | 200 | 79 | 5 | f0452dc1056b5ea492e61b20bb52815a5d2f705e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.85e-05 | 200 | 79 | 5 | 2bd8c35484fe6b0bc0f9314216786baaa97d1e95 | |
| ToppCell | COVID-19-Fibroblasts-Vascular_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 2.85e-05 | 200 | 79 | 5 | c7f82196a0768ad96b1df8b8915bc541fb118a76 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.85e-05 | 200 | 79 | 5 | 024eafabb576bfb835452def941237a35eebb912 | |
| ToppCell | remission-CD8+_Tem|remission / disease stage, cell group and cell class | 2.85e-05 | 200 | 79 | 5 | f1e4b8fcb422727f665f22b48f34bee23f0fad52 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.85e-05 | 200 | 79 | 5 | 6c2543ff19a81c898f9e07d1fea97d16fa96e2bc | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.85e-05 | 200 | 79 | 5 | 64c2399c78e4ce0f05893d856bf90b1d3f5dba03 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.85e-05 | 200 | 79 | 5 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.85e-05 | 200 | 79 | 5 | 94d4f690bf5b87866c0840715396d360b1737d11 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-CD8+_Tem|COVID-19_Convalescent / Disease group, lineage and cell class | 2.85e-05 | 200 | 79 | 5 | 3f00839697183a1066548930b9ec3664b3568afc | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.85e-05 | 200 | 79 | 5 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.85e-05 | 200 | 79 | 5 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | ASK440-Epithelial|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.85e-05 | 200 | 79 | 5 | cb617e2a0ca82b470b473b8d5906bc8879c85718 | |
| ToppCell | COVID-19_Mild-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 7.04e-05 | 124 | 79 | 4 | 5ef9eb806fb2c8ee5aae0a75503d244b08ee10d4 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.16e-04 | 141 | 79 | 4 | 737237db115721524c44ea4c55aed000e1b00ee5 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-04 | 141 | 79 | 4 | c14f84bc3921cafbce6fa7f7163ecf3cd9cdf073 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.19e-04 | 142 | 79 | 4 | f720f13b339589fa924a42e89393e5db0b26300b | |
| ToppCell | LA-15._Ventricular_Cardiomyocyte_III|LA / Chamber and Cluster_Paper | 1.36e-04 | 147 | 79 | 4 | 8970eb6b82589f39439c61a57d999661ec8342de | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-4|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.43e-04 | 149 | 79 | 4 | ff472ad641efd655905e99a9a4cacd5245ab8854 | |
| ToppCell | LPS_only-Lymphocytic_NKT-iNKT/MAIT-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 151 | 79 | 4 | 7270b8bbfae659e110bd9d513b602120b25de3dd | |
| ToppCell | facs-Trachea-nan-24m-Myeloid-granulocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 151 | 79 | 4 | 26fd55efb647c41436416d45952ee97b050e632c | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.71e-04 | 156 | 79 | 4 | 574f761962a7dd3308bd41fc529dd3ea1b8625f8 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.71e-04 | 156 | 79 | 4 | 605d95a900e1443d3f6aae163ef2e893d3293203 | |
| ToppCell | PND07-28-samps|World / Age Group, Lineage, Cell class and subclass | 1.75e-04 | 157 | 79 | 4 | a2005768a6d268879e3fd6dbd8cf674dc98be587 | |
| ToppCell | droplet-Kidney-nan-18m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 157 | 79 | 4 | eb64a4e89843895d16015c7d51805f164ed7ea5b | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-granulocyte-granulocyte_l8|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.75e-04 | 157 | 79 | 4 | 5098675f64342c41c5ca3551b24962d10c83e64d | |
| ToppCell | facs-MAT-Fat-18m-Myeloid-myeloid_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 160 | 79 | 4 | bd5fa7959bfe81011b8d798535b73ea1eee008b3 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-04 | 163 | 79 | 4 | 63b0badaee3b2d827b1f4524510e3384d8f8fcde | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-04 | 165 | 79 | 4 | 6d315e0734079ad05336cc2c3f24d870c9105bc8 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-04 | 165 | 79 | 4 | 84f5597b1bb75f42de9a224196bb8ac198bbe3bf | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.12e-04 | 165 | 79 | 4 | 8a82e20c9b1156bb4bbc16f7785abb04458d671b | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 168 | 79 | 4 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| ToppCell | droplet-Marrow-nan-21m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-04 | 171 | 79 | 4 | d6ae456e88ec49a8609a5e5e3af9f51921e66744 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Neutrophil|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-04 | 171 | 79 | 4 | ef9397cec7f5c217d34583f26270af7ed7fbcebf | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.48e-04 | 172 | 79 | 4 | eb199c279fe8a2551121db37e9556893197d33ff | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.48e-04 | 172 | 79 | 4 | 584af6537685cb459bf0fc298e6f46872016c116 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.48e-04 | 172 | 79 | 4 | 709c6b77a7a52b873eefb6caca28a41291d384af | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.53e-04 | 173 | 79 | 4 | ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs|normal_Lymph_Node / Location, Cell class and cell subclass | 2.53e-04 | 173 | 79 | 4 | 38f88f5bbf92a3bf5109bc4782cd071b7cb1ca34 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.53e-04 | 173 | 79 | 4 | 3725525b99a6011eda2ff5459b4fd2e1eab1f090 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.53e-04 | 173 | 79 | 4 | 36a471576a9d2325066bb14c2f2cd89c67b92915 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.59e-04 | 174 | 79 | 4 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.65e-04 | 175 | 79 | 4 | 41174b7381932a2cc94063c7202eeff6d3208cc7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.70e-04 | 176 | 79 | 4 | 5914e7635474e7cf24d446bdb1423bc0807ee9c6 | |
| Drug | lamotrigine | CACNA1C CACNA1D CACNA1F SCN4A SCN5A PKD2 SCN10A SLC43A3 RYR2 | 2.29e-10 | 116 | 78 | 9 | CID000003878 |
| Drug | NSC7524 | CACNA1C CACNA1D CACNA1F HCAR3 HCAR2 SCN4A SCN5A PKD2 SCN10A RYR2 | 6.54e-10 | 182 | 78 | 10 | CID000005657 |
| Drug | Verapamil | 1.76e-09 | 16 | 78 | 5 | DB00661 | |
| Drug | procaine | 2.71e-09 | 153 | 78 | 9 | CID000004914 | |
| Drug | verapamil | CACNA1C CACNA1D ABCG4 CACNA1F HCAR3 HCAR2 ABCG1 SLC22A5 SCN4A SCN5A PKD2 SCN10A RYR2 | 1.12e-08 | 490 | 78 | 13 | CID000002520 |
| Drug | bepridil | 1.19e-08 | 126 | 78 | 8 | CID000002351 | |
| Drug | Cinildipine | 3.77e-08 | 56 | 78 | 6 | CID000002752 | |
| Drug | isradipine | 5.22e-08 | 100 | 78 | 7 | CID000003784 | |
| Drug | lercanidipine | 7.73e-08 | 63 | 78 | 6 | CID000065866 | |
| Drug | CNS 1145 | 9.12e-08 | 33 | 78 | 5 | CID000190902 | |
| Drug | IHC-64 | 9.12e-08 | 33 | 78 | 5 | CID000162753 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | MYL12A SLC6A4 CACNA1C CACNA1D CACNA1F MYL9 SERPINE1 PKD2 MYL12B RYR2 | 9.91e-08 | 308 | 78 | 10 | CID000001915 |
| Drug | gallopamil | 1.12e-07 | 67 | 78 | 6 | CID000001234 | |
| Drug | gabapentin | 1.18e-07 | 169 | 78 | 8 | CID000003446 | |
| Drug | riluzole | 1.47e-07 | 174 | 78 | 8 | CID000005070 | |
| Drug | pilsicainide | 5.09e-07 | 46 | 78 | 5 | CID000004820 | |
| Drug | nicardipine | 6.65e-07 | 145 | 78 | 7 | CID000004473 | |
| Drug | phenytoin | 8.48e-07 | 219 | 78 | 8 | CID000001775 | |
| Drug | halothane | CACNA1C CACNA1D CACNA1F HCAR3 HCAR2 PKD2 CYP2U1 SLC45A2 RYR2 | 1.27e-06 | 314 | 78 | 9 | CID000003562 |
| Drug | nifedipine | MYL12A CACNA1C CACNA1D CACNA1F MYL9 PKD2 CYP2U1 SLC45A2 MYL12B RYR2 | 1.52e-06 | 415 | 78 | 10 | CID000004485 |
| Drug | nilvadipine | 1.95e-06 | 60 | 78 | 5 | CID000004494 | |
| Drug | IAA-94 | 2.12e-06 | 61 | 78 | 5 | CID000003667 | |
| Drug | Cocaine | 2.14e-06 | 8 | 78 | 3 | DB00907 | |
| Drug | disopyramide | 3.15e-06 | 66 | 78 | 5 | CID000003114 | |
| Drug | Cinnarizine | 3.20e-06 | 9 | 78 | 3 | DB00568 | |
| Drug | Nimodipine | 3.20e-06 | 9 | 78 | 3 | DB00393 | |
| Drug | sodium | SLC6A4 CACNA1C CACNA1D HCAR3 HCAR2 SLC18A1 SLC22A5 SCN4A SCN5A PKD2 SCN10A SLC43A3 RYR2 SLC5A4 | 3.48e-06 | 944 | 78 | 14 | CID000000923 |
| Drug | AC1L2AC7 | 3.92e-06 | 69 | 78 | 5 | CID000068733 | |
| Drug | propofol | 4.18e-06 | 191 | 78 | 7 | CID000004943 | |
| Drug | dihydropyridine | 4.48e-06 | 193 | 78 | 7 | CID000104822 | |
| Drug | CAS 298-57-7 | 5.19e-06 | 73 | 78 | 5 | CID000002761 | |
| Drug | ethosuximide | 5.55e-06 | 74 | 78 | 5 | CID000003291 | |
| Drug | U46619 | 6.00e-06 | 285 | 78 | 8 | CID000005618 | |
| Drug | Mibefradil | 6.26e-06 | 11 | 78 | 3 | DB01388 | |
| Drug | nisoldipine | 7.20e-06 | 78 | 78 | 5 | CID000004499 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 7.66e-06 | 79 | 78 | 5 | CID005287890 | |
| Drug | AC1NSVQS | 8.32e-06 | 12 | 78 | 3 | CID005317517 | |
| Drug | bupropion | 8.66e-06 | 81 | 78 | 5 | CID000000444 | |
| Drug | quindine | 1.02e-05 | 219 | 78 | 7 | CID000001065 | |
| Drug | Hexylcaine | 1.16e-05 | 2 | 78 | 2 | DB00473 | |
| Drug | Flecainide | 1.16e-05 | 2 | 78 | 2 | DB01195 | |
| Drug | QX-222 | 1.29e-05 | 42 | 78 | 4 | CID000005014 | |
| Drug | Oxycodone | 1.44e-05 | 153 | 78 | 6 | ctd:D010098 | |
| Drug | escina | 1.56e-05 | 44 | 78 | 4 | CID006433489 | |
| Drug | FPL 64176 | 1.71e-05 | 15 | 78 | 3 | CID000003423 | |
| Drug | 2-nitrofluorene | 1.86e-05 | 46 | 78 | 4 | CID000011831 | |
| Drug | manidipine | 1.89e-05 | 95 | 78 | 5 | CID000004008 | |
| Drug | isotetrandrine | 2.09e-05 | 97 | 78 | 5 | CID000005422 | |
| Drug | caffeine | CACNA1C CACNA1D CACNA1F HCAR3 HCAR2 PKD2 B4GALNT2 CYP2U1 SLC38A6 RYR2 | 2.16e-05 | 562 | 78 | 10 | CID000002519 |
| Drug | nitrendipine | 2.19e-05 | 98 | 78 | 5 | CID000004507 | |
| Drug | felodipine | 2.53e-05 | 169 | 78 | 6 | CID000003333 | |
| Drug | tetrapropylammonium | 2.54e-05 | 17 | 78 | 3 | CID000009559 | |
| Drug | tetrapentylammonium | 2.54e-05 | 17 | 78 | 3 | CID000017248 | |
| Drug | etridiazole | 2.60e-05 | 50 | 78 | 4 | CID000017432 | |
| Drug | noradrealine | SLC6A4 CACNA1C CACNA1D CACNA1F HCAR3 HCAR2 SLC18A1 PKD2 SLC45A2 RYR2 | 2.63e-05 | 575 | 78 | 10 | CID000000951 |
| Drug | loperamide | 3.06e-05 | 105 | 78 | 5 | CID000003954 | |
| Drug | papaverine | 3.17e-05 | 176 | 78 | 6 | CID000004680 | |
| Drug | Dibucaine | 3.47e-05 | 3 | 78 | 2 | DB00527 | |
| Drug | (endo-N-8-methyl-8-azabicyclo-(3.2.1)oct-3-yl)-2,3-dihydro-3-isopropyl-2-oxo-1H-benzimidazol-1-carboxamide | 3.47e-05 | 3 | 78 | 2 | ctd:C070189 | |
| Drug | gamma-aminobutyric acid | SLC6A4 CACNA1C CACNA1D CACNA1F HCAR3 HCAR2 SLC18A1 PKD2 RYR2 | 3.48e-05 | 474 | 78 | 9 | CID000000119 |
| Drug | carbamazepine | 3.49e-05 | 179 | 78 | 6 | CID000002554 | |
| Drug | potassium | MYL12A CACNA1C CACNA1D CACNA1F HCAR3 HCAR2 MYL9 SCN4A SCN5A PKD2 SCN10A MYL12B RYR2 | 3.54e-05 | 1008 | 78 | 13 | CID000000813 |
| Drug | Nifedipine | 4.18e-05 | 112 | 78 | 5 | ctd:D009543 | |
| Drug | 1 SA | 4.23e-05 | 20 | 78 | 3 | CID011987857 | |
| Drug | TA 98 | 4.23e-05 | 20 | 78 | 3 | CID000016749 | |
| Drug | Calcium | 4.72e-05 | 493 | 78 | 9 | ctd:D002118 | |
| Drug | valproate | 4.83e-05 | 381 | 78 | 8 | CID000003121 | |
| Drug | isoflurane | 4.84e-05 | 279 | 78 | 7 | CID000003763 | |
| Drug | procainamide | 4.87e-05 | 190 | 78 | 6 | CID000004913 | |
| Drug | AC1NBU2S | 5.15e-05 | 117 | 78 | 5 | CID004473765 | |
| Drug | azido-IQ | 6.92e-05 | 4 | 78 | 2 | CID000115105 | |
| Drug | NSC-686960 | 6.92e-05 | 4 | 78 | 2 | CID000192816 | |
| Drug | Lidocaine | 6.92e-05 | 4 | 78 | 2 | DB00281 | |
| Drug | Niacin | 6.92e-05 | 4 | 78 | 2 | DB00627 | |
| Drug | succinylcholine | 6.93e-05 | 64 | 78 | 4 | CID000005314 | |
| Drug | mibefradil | 6.93e-05 | 64 | 78 | 4 | CID000060662 | |
| Drug | AC1L1DXE | 7.48e-05 | 299 | 78 | 7 | CID000002548 | |
| Drug | pimozide | 7.60e-05 | 127 | 78 | 5 | CID000016362 | |
| Drug | mexiletine | 7.82e-05 | 66 | 78 | 4 | CID000004178 | |
| Drug | NO-711 | 7.82e-05 | 66 | 78 | 4 | CID000004515 | |
| Drug | AC1NSKJI | 8.79e-05 | 68 | 78 | 4 | CID005311391 | |
| Drug | STA2 | 8.79e-05 | 68 | 78 | 4 | CID005311453 | |
| Drug | GBR 12909 | 9.30e-05 | 69 | 78 | 4 | CID000003455 | |
| Drug | isoproterenol | MYL12A CACNA1C CACNA1D CACNA1F MYL9 SCN4A SCN5A SCN10A MYL12B RYR2 | 9.33e-05 | 669 | 78 | 10 | CID000003779 |
| Drug | AC1L1KC5 | CACNA1C CACNA1D CACNA1F HCAR3 HCAR2 SLC49A4 PKD2 B4GALNT2 RYR2 | 9.61e-05 | 541 | 78 | 9 | CID000005428 |
| Drug | caged ATP | 9.84e-05 | 70 | 78 | 4 | CID000123806 | |
| Drug | genistein | MYL12A SLC6A4 CACNA1C CACNA1D CACNA1F PPP2R2C MYL9 SERPINE1 PKD2 SLC45A2 ITGAL MYL12B RYR2 | 1.01e-04 | 1117 | 78 | 13 | CID005280961 |
| Drug | 1-(5-isoquinolinesulfonyl)-2-methylpiperazine | 1.01e-04 | 314 | 78 | 7 | CID000003542 | |
| Drug | amiloride | 1.03e-04 | 315 | 78 | 7 | CID000016230 | |
| Drug | flecainide | 1.04e-04 | 71 | 78 | 4 | CID000003355 | |
| Drug | lanthanum | 1.05e-04 | 136 | 78 | 5 | CID000023926 | |
| Drug | AC1L1MOZ | 1.07e-04 | 27 | 78 | 3 | CID000031958 | |
| Drug | tetradotoxin | 1.08e-04 | 428 | 78 | 8 | CID000020382 | |
| Drug | Nilvadipine | 1.15e-04 | 5 | 78 | 2 | DB06712 | |
| Drug | Nisoldipine | 1.15e-04 | 5 | 78 | 2 | DB00401 | |
| Drug | azido-PhIP | 1.15e-04 | 5 | 78 | 2 | CID000154466 | |
| Drug | cinnamomin | 1.15e-04 | 5 | 78 | 2 | CID000146575 | |
| Drug | B 874-67 | 1.15e-04 | 5 | 78 | 2 | CID000195466 | |
| Drug | methyl beta-aminocrotonate | 1.15e-04 | 5 | 78 | 2 | CID000084253 | |
| Drug | nemadipine-A | 1.15e-04 | 5 | 78 | 2 | CID002856102 | |
| Disease | Timothy syndrome (implicated_via_orthology) | 5.56e-08 | 4 | 72 | 3 | DOID:0060173 (implicated_via_orthology) | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 6.00e-07 | 200 | 72 | 7 | EFO_0004611, EFO_0020945 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.65e-06 | 10 | 72 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.65e-06 | 10 | 72 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | Shortened QT interval | 2.27e-06 | 11 | 72 | 3 | C0151879 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 3.02e-06 | 12 | 72 | 3 | DOID:1441 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 3.02e-06 | 12 | 72 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Renal carnitine transport defect | 5.87e-06 | 2 | 72 | 2 | C0342788 | |
| Disease | Arrhythmogenic Right Ventricular Dysplasia | 1.76e-05 | 3 | 72 | 2 | C0349788 | |
| Disease | cocaine abuse (implicated_via_orthology) | 1.76e-05 | 3 | 72 | 2 | DOID:809 (implicated_via_orthology) | |
| Disease | Brugada Syndrome (disorder) | 2.72e-05 | 24 | 72 | 3 | C1142166 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 2.91e-05 | 243 | 72 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | triglyceride measurement, phospholipid measurement | 2.97e-05 | 146 | 72 | 5 | EFO_0004530, EFO_0004639 | |
| Disease | resting heart rate | 3.27e-05 | 149 | 72 | 5 | EFO_0004351 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 3.38e-05 | 150 | 72 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | Brugada ECG Pattern | 3.51e-05 | 4 | 72 | 2 | C1721096 | |
| Disease | Auriculo-Ventricular Dissociation | 3.51e-05 | 4 | 72 | 2 | C0004331 | |
| Disease | Heart Block | 3.51e-05 | 4 | 72 | 2 | C0018794 | |
| Disease | diastolic blood pressure, systolic blood pressure | MYL12A CACNA1C CACNA1D MYL9 SCN5A SERPINE1 PTCD2 DENND2B RYR2 | 3.62e-05 | 670 | 72 | 9 | EFO_0006335, EFO_0006336 |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 4.62e-05 | 264 | 72 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 5.91e-05 | 276 | 72 | 6 | EFO_0004612, EFO_0020943 | |
| Disease | Sick Sinus Syndrome | 8.75e-05 | 6 | 72 | 2 | C0037052 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 9.39e-05 | 36 | 72 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | electrocardiography, PR interval | 1.22e-04 | 7 | 72 | 2 | EFO_0004327, EFO_0004462 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 1.51e-04 | 206 | 72 | 5 | EFO_0004612, EFO_0020947 | |
| Disease | Brugada syndrome | 1.63e-04 | 8 | 72 | 2 | cv:C1142166 | |
| Disease | eye disease | 1.84e-04 | 45 | 72 | 3 | EFO_0003966 | |
| Disease | supraventricular ectopy | 2.09e-04 | 9 | 72 | 2 | EFO_0009277 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 2.14e-04 | 222 | 72 | 5 | EFO_0008317, EFO_0020943 | |
| Disease | Cardiomyopathy, Dilated | 2.23e-04 | 48 | 72 | 3 | C0007193 | |
| Disease | Kidney Failure, Chronic | 2.23e-04 | 48 | 72 | 3 | C0022661 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 2.28e-04 | 225 | 72 | 5 | EFO_0008317, EFO_0020947 | |
| Disease | Tachycardia, Ventricular | 3.18e-04 | 11 | 72 | 2 | C0042514 | |
| Disease | Long QT Syndrome | 3.18e-04 | 11 | 72 | 2 | C0023976 | |
| Disease | lifestyle measurement, anxiety disorder measurement | 3.58e-04 | 137 | 72 | 4 | EFO_0007795, EFO_0010724 | |
| Disease | Hypertrophic Cardiomyopathy | 3.71e-04 | 57 | 72 | 3 | C0007194 | |
| Disease | Pathological accumulation of air in tissues | 3.81e-04 | 12 | 72 | 2 | C0013990 | |
| Disease | Sudden infant death syndrome | 3.81e-04 | 12 | 72 | 2 | C0038644 | |
| Disease | cholesterol to total lipids in IDL percentage | 4.31e-04 | 60 | 72 | 3 | EFO_0022233 | |
| Disease | Brugada Syndrome 1 | 4.50e-04 | 13 | 72 | 2 | C4551804 | |
| Disease | HDL cholesterol change measurement, physical activity | 4.75e-04 | 62 | 72 | 3 | EFO_0003940, EFO_0007805 | |
| Disease | T wave morphology measurement | 5.24e-04 | 14 | 72 | 2 | EFO_0008398 | |
| Disease | Liver Cirrhosis, Experimental | 5.89e-04 | 774 | 72 | 8 | C0023893 | |
| Disease | Sinus Node Dysfunction (disorder) | 6.04e-04 | 15 | 72 | 2 | C0428908 | |
| Disease | P wave duration | 6.04e-04 | 15 | 72 | 2 | EFO_0005094 | |
| Disease | intracerebral hemorrhage | 6.89e-04 | 16 | 72 | 2 | EFO_0005669 | |
| Disease | Romano-Ward Syndrome | 6.89e-04 | 16 | 72 | 2 | C0035828 | |
| Disease | cathepsin L1 measurement | 6.89e-04 | 16 | 72 | 2 | EFO_0010619 | |
| Disease | Manic Disorder | 7.07e-04 | 71 | 72 | 3 | C0024713 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 7.35e-04 | 291 | 72 | 5 | EFO_0008317, EFO_0020946 | |
| Disease | Vascular Diseases | 7.80e-04 | 17 | 72 | 2 | C0042373 | |
| Disease | theta wave measurement | 7.80e-04 | 17 | 72 | 2 | EFO_0006873 | |
| Disease | Manic | 9.29e-04 | 78 | 72 | 3 | C0338831 | |
| Disease | Depression, Bipolar | 9.64e-04 | 79 | 72 | 3 | C0005587 | |
| Disease | Brugada syndrome | 9.77e-04 | 19 | 72 | 2 | MONDO_0015263 | |
| Disease | Bipolar Disorder | 1.10e-03 | 477 | 72 | 6 | C0005586 | |
| Disease | PR interval | 1.33e-03 | 495 | 72 | 6 | EFO_0004462 | |
| Disease | sciatic neuropathy (implicated_via_orthology) | 1.44e-03 | 23 | 72 | 2 | DOID:11446 (implicated_via_orthology) | |
| Disease | Anhedonia | 1.57e-03 | 24 | 72 | 2 | C0178417 | |
| Disease | Behcet Syndrome | 1.57e-03 | 24 | 72 | 2 | C0004943 | |
| Disease | Involutional paraphrenia | 1.70e-03 | 25 | 72 | 2 | C1571983 | |
| Disease | Psychosis, Involutional | 1.70e-03 | 25 | 72 | 2 | C1571984 | |
| Disease | Involutional Depression | 1.70e-03 | 25 | 72 | 2 | C0011574 | |
| Disease | Cardiac Arrhythmia | 1.70e-03 | 25 | 72 | 2 | C0003811 | |
| Disease | Depressive Symptoms | 1.84e-03 | 26 | 72 | 2 | C0086132 | |
| Disease | Calcium channel blocker use measurement | 1.85e-03 | 213 | 72 | 4 | EFO_0009930 | |
| Disease | corpus callosum mid-anterior volume measurement | 1.98e-03 | 27 | 72 | 2 | EFO_0010297 | |
| Disease | blood strontium measurement | 1.98e-03 | 27 | 72 | 2 | EFO_0021531 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 2.07e-03 | 103 | 72 | 3 | EFO_0008595, EFO_0020944 | |
| Disease | bipolar disorder (is_implicated_in) | 2.28e-03 | 29 | 72 | 2 | DOID:3312 (is_implicated_in) | |
| Disease | cardiovascular age measurement | 2.28e-03 | 29 | 72 | 2 | EFO_0803380 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NLMLTAFMENFTFSG | 151 | Q9UKU6 | |
| FNNTGCLFFSMLFLM | 421 | Q9H172 | |
| SVIMTGSYNNFFRMF | 351 | Q00005 | |
| SVIMTGAYNNFFRMF | 351 | Q9Y2T4 | |
| ASFGFEMEMFEFLNI | 51 | Q5VTM2 | |
| GFLFFSMLFLMFAAL | 456 | P45844 | |
| VVMTGSYNNFFRMFD | 356 | P63151 | |
| FMFGSMFLQAVFSSP | 86 | Q8NHY0 | |
| FIFSFRNTQEVMAMN | 1731 | Q7Z2Y8 | |
| LISNMTFMLPFQFFN | 236 | Q01954 | |
| RFLEVFMESQMFAGF | 1071 | P78524 | |
| ELVGAQMLFSFMSLF | 271 | Q7L4S7 | |
| QMLFSFMSLFIRNGN | 276 | Q7L4S7 | |
| NFTMFLTMFGEKLNG | 81 | P19105 | |
| MRFQQFLFAFFIFIM | 1 | P0DMC3 | |
| FAGASEMFLLTVMAF | 106 | A0A0X1KG70 | |
| FVEPMLSFFQGMFTF | 196 | A1A4S6 | |
| DFNFDNVLSAMMALF | 1066 | O60840 | |
| FGGCLLQMFFIHMFT | 96 | Q8NGH9 | |
| FLGGAMVFFLSVMAF | 106 | P58180 | |
| NFLMQVLSFIFIMGN | 836 | Q9HCI5 | |
| LMGIFFSTLFVFMDS | 236 | Q9UPQ8 | |
| FFITLSFTYMNSMLD | 276 | Q8TDS4 | |
| INFTMFLTMFGEKLN | 81 | P24844 | |
| SSQDQGMFLMLFYNI | 266 | Q7Z3T1 | |
| FAGASEMFLLTVMAF | 106 | Q8NGB6 | |
| ESFSARMNFLAAMPF | 1156 | Q5S007 | |
| ISFAGRMMQTFLFST | 91 | Q96R45 | |
| VAFMFMFTAFQTCGN | 16 | O43934 | |
| MEKLNMFQGFFDSQT | 2331 | Q9UPN3 | |
| ISFAGRMMQTFLFST | 91 | O95047 | |
| FLFTMSFFNFAMPLF | 176 | P47804 | |
| FLMFVSLMQSFAFAL | 501 | Q7Z449 | |
| AQNIMESFENPFRMF | 681 | Q01780 | |
| FDFDNVLAAMMALFT | 1116 | Q13936 | |
| TFLSNMFMGVLLFFL | 421 | Q96SL1 | |
| GLFSLVFLFNMAMLA | 576 | Q9Y653 | |
| QRAMMANRLSFFFDF | 136 | P49327 | |
| ALTFIPSIMSAFFMF | 71 | Q9Y267 | |
| SALQKMALGMFFGFT | 406 | Q8IY34 | |
| NVLFVTMGMQTGFSF | 171 | O76082 | |
| TMGMQTGFSFLQIFS | 176 | O76082 | |
| FLSNMLFFTDFMGQI | 331 | Q9UMX9 | |
| QSFSAMALLFYTVFM | 151 | Q9HBR0 | |
| SSNNVEMILKFFDMF | 4006 | Q92736 | |
| NMRMLALFVAFAINF | 4501 | Q92736 | |
| DFNFDNVLSAMMALF | 1081 | Q01668 | |
| FFSDSTSFNILMDML | 161 | Q8WV60 | |
| LGMTDMFRQFQADFT | 316 | P05121 | |
| SGNQTMVTEFLFSMF | 31 | Q8NGW6 | |
| LTQMYFFLMFGDLDS | 96 | Q8NGS0 | |
| INFTMFLTMFGEKLN | 81 | O14950 | |
| LIFSFSEVMFAMKQF | 401 | O75691 | |
| LVMFIYSIFGMSNFA | 1491 | P35499 | |
| GFCFTALMGMFNSIF | 146 | Q9UM00 | |
| AFLFDSTLTAFLMMG | 51 | P0C866 | |
| FFITLSFTYMNSMLD | 276 | P49019 | |
| FFLFMLLAMFSASST | 6 | A0A1B0GUY1 | |
| SLSFFFMMFFALVVI | 196 | Q8IZM9 | |
| MFNFQTFANSMLCLF | 1691 | Q14524 | |
| MLIGSFILMGFAFNE | 211 | Q9NY91 | |
| SLIFTLGSFMNNFMT | 71 | Q8NBI5 | |
| SFGVFLMNSNAMEIF | 291 | P14410 | |
| ITVMAMALLSGFFFF | 6 | P20701 | |
| FFGRAFNMFALRNMS | 101 | H7C241 | |
| GFIASFMFLLDFITM | 141 | Q9NX76 | |
| LKMFTDFLSFMVLFN | 341 | Q8NB49 | |
| LFFFTFFITTMVMLA | 831 | Q9NR97 | |
| QMMFGVNFFSCLFTV | 301 | Q8TB61 | |
| MFNFQTFANSMLCLF | 1641 | Q9Y5Y9 | |
| FTTFVFFMFFILLNM | 661 | Q13563 | |
| VIFFQQGMLPAMSFD | 191 | Q16222 | |
| NAIMFLFVLANFSMA | 51 | Q9C0B5 | |
| LFVLANFSMATFMDP | 56 | Q9C0B5 | |
| LFVLANFSMATFMDP | 56 | Q9ULC8 | |
| TFFMIQNAGMLTGFT | 431 | Q9C0K1 | |
| QMMTFFIFLLFFPSF | 831 | Q6UXY8 | |
| IMFLFFAAAMFSVSL | 211 | Q9UIJ5 | |
| ALMMLFNDGTFQVNF | 611 | Q9NYY3 | |
| AMFFSLQGIFGIMSS | 221 | Q8N8F6 | |
| LMSFGASFVSFLNAM | 61 | Q8N584 | |
| NMPASTFFAIIFFLM | 416 | P31645 | |
| FGFARYLQSNMMAAT | 166 | O75385 | |
| FAGFVIMFLSTVMFA | 171 | P54219 |